Brief: Sedana Medical Q1 Operating Loss Widens To SEK 22 Mln

Sedana Medical AB (publ)

28/04/2022 06:13

April 28 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * SEDANA MEDICAL AB INTERIM REPORT JANUARY-MARCH 2022
    * Q1 NET SALES TOTALLED MSEK 34 (45), EQUIVALENT TO A
DECREASE OF
25% COMPARED TO Q1 OF 2021
    * Q1 GROSS PROFIT WAS MSEK 23 (29), EQUIVALENT TO A MARGIN
OF 68%
(64%)
    * Q1 OPERATING INCOME (EBIT) TOTALLED MSEK -22 (-10)
EQUIVALENT TO
AN EBIT MARGIN OF -66% (-23%).
    * Q1 NET PROFIT FOR QUARTER WAS MSEK -19 (-9)

Source text for Eikon:  ID:nWkrgGdfD 
Further company coverage:  SEDANA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))